Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Board/Management Information 2021

Feb 3, 2021

61842_rns_2021-02-03_f2b3fdb1-a295-4e87-9f24-0710c56eb50d.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited Batra Centre

No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in

February 3, 2021

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Scrip Code: 541540

Scrip Code: SOLARA

Dear Sirs,

Sub: Appointment of Mr. Subash Anand as Executive Director and CFO

The Board at its meeting held today (February 3, 2021), appointed Mr. Subash Anand (DIN: 07348933) as Executive Director and CFO of the Company with effect from April 01, 2021.

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015 is enclosed.

We request you to take the same on record.

Thanking you, Yours faithfully,

For Solara Active Pharma Sciences Limited

==> picture [146 x 39] intentionally omitted <==

S. Murali Krishna Company Secretary

Encl: Disclosure.

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address: Solara Active Pharma Sciences Limited Batra Centre

No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Appointment of Mr. Subash Anand as Executive Director and Chief Financial Officer (ED & CFO)

No. Particulars Remarks Remarks
1. Reason
for
change
viz.,
appointment or otherwise
Mr. Subash Anand appointed as ED & CFO
2. Date of Appointment August 19,2020
3. Effective date of appointment
as ED & CFO
April 01, 2021
4. Brief Profile Subhash is a qualified AICWA (India) & Certified
Management Accountant (CMA) from the Institute of
Management Accountants (USA) with 30+ years of
manaerial
and
rofessional
exerience
with
g

p
p

Multinational and Indian companies. His last held position
was as President & CFO at PI Industries Ltd (PIIL). Prior to
PIIL, he worked in Whirlpool, Sterlite Industries, Hindustan
Copper Ltd and Calcom in senior finance roles.
5. Disclosure
of
relationship
between directors
Mr. Subash Anand, is not related to any promoter, director
or keymanagerialpersonnel of the company.

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942